Remy Cointreau

Is Remy on the path to recovery?

28/11/24 -"The figures for Rémy’s H1 were largely unsurprising. The newly quantified outlook is expected to lead to a 17% consensus revision. While the situation in China shows no signs of improvement, it ..."

PDF page sample
Pages
65
Language
English
Published on
28/11/24
Download
You may also be interested by these reports :
28/10/26
Ebro Foods delivered a resilient 9M performance despite a challenging operating environment. Rice continued to support group profitability, ...
28/10/26
Campari delivered another quarter of organic growth, confirming that its strategy of fewer, bigger bets is gaining traction. Europe and aperitifs ...
28/10/26
Danone delivered another top-line beat, mainly driven by pricing, as volume/mix fell short of expectations. Operational issues in US dairy and a ...
28/10/26
Rémy Cointreau delivered another encouraging quarter, but the underlying picture is less convincing than the headline suggests. Stronger Cognac ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO